Thermo Fisher Scientific Inc.
TMO | NYSE
$649.91
-$1.54 (-0.24%)
Sep 21, 2026, 10:25 AM ET · Market open
Market Data
Market Cap $242.09B
Enterprise Value $280.58B
Beta 0.85
Average Volume 2.17M
Shares Outstanding (Diluted) 371M
Shares Change YoY -1.85%
Institutional Ownership 89.33%
Exchange NYSE
ISIN US8835561023
Price Performance
Price Change 1M 9.5%
Price Change 3M 40.4%
Price Change 6M 36.3%
Price Change YTD 9.9%
Price Change 1Y 35.4%
Price Change 3Y 29.6%
Price Change 5Y 6.8%
1M CAGR (ann.) 12.4%
1Y CAGR (ann.) 38.3%
5Y CAGR (ann.) 2.9%
All-Time CAGR 15.0%
Valuation
PE Ratio 35.04
Forward PE 23.87
PEG Ratio 4.70
Forward PEG 3.82
PS Ratio 5.22
Forward PS 4.80
PB Ratio 4.60
P/FCF Ratio 33.08
P/Adj. FCF Ratio 33.47
P/OCF Ratio 26.82
EV/Sales 6.06
EV/EBIT 32.51
EV/EBITDA 25.66
EV/FCF 38.34
Earnings Yield 2.9%
FCF Yield 3.0%
Adj. FCF Yield 3.0%
Financial Health
Net Debt $38.49B
Total Debt $42.55B
Cash & Short-Term Investments $4.06B
Total Assets $113.17B
Current Ratio 1.55
Quick Ratio 1.18
Debt / Equity Ratio 0.81
Debt / EBITDA 3.89
Debt / FCF 5.81
OCF / Debt 0.21
Interest Coverage 5.59
Altman Z-Score 3.15
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 40.4%
Operating Profit Margin 17.7%
EBITDA Margin 23.6%
Net Profit Margin 15.1%
FCF Margin 15.8%
Adj. FCF Margin 15.6%
SBC / Revenue 0.2%
SBC Impact (per share) -1.1%
Returns
Return on Assets 6.2%
Return on Equity 13.3%
Return on Invested Capital 7.4%
Return on Capital Employed 8.3%
Return on Tangible Assets 17.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 2.1%
Revenue CAGR 5Y 3.9%
Revenue CAGR 10Y 10.2%
EPS CAGR 3Y 8.3%
EPS CAGR 5Y -2.9%
EPS CAGR 10Y 14.1%
FCF CAGR 3Y 7.7%
FCF CAGR 5Y -2.1%
FCF CAGR 10Y 10.5%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 43
EPS Growth Next 3Y 22.2%
Revenue Growth Next 3Y 7.2%
Earnings Date Oct 27, 2026
EPS Estimate (next Q) $6.40
EPS Growth Est (next Q) 10.5%
Revenue Est (next Q) $11.95B
Revenue Growth Est (next Q) 7.5%
Fair Value Estimates
Graham Number $243.72
Graham Upside -62.6%
Lynch Fair Value $92.95
Lynch Upside -85.7%
Price Target $623.36
Price Target Upside -4.3%
Cash Flow
Operating Cash Flow $9.01B
Free Cash Flow $7.32B
Adj. Free Cash Flow $7.23B
FCF Per Share $19.73
OCF Per Share $24.29
OCF/S Ratio 19.5%
Income Statement
Revenue $46.34B
Gross Profit $18.71B
Operating Income $8.2B
EBITDA $10.94B
Net Income $6.98B
EPS (Diluted) $18.59
Revenue / Employee $370.69K
Profit / Employee $55.82K
Employees 125,000
Dividends
Annual Dividend $1.84
Dividend Yield 0.28%
Payout Ratio 9.9%
FCF Payout Ratio 9.1%
Adj. FCF Payout Ratio 9.2%
Dividend Growth (YoY) 9.5%
Pay Frequency Quarterly
Ex-Dividend Date Sep 14, 2026
Add to Watchlist
Select watchlists to add or remove TMO